The positive percentage of serum tumor biomarkers including CEA (Carcino-embryonic antigen) and CYFRA 21-1(Cytokeratin-19-fragment) was 36.4 and 40.9%, respectively, in these NSCLC patients. Here, CEACAM5 is linked to non-small cell lung carcinoma.